Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study

This publication has 16 references indexed in Scilit:

• Cancer statistics, 1998
  CA: A Cancer Journal for Clinicians, 1998
• Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy
  Urology, 1997
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
  Published by American Medical Association (AMA) ,1997
• Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands
  Urology, 1994
• Relationship between prostatc epithelial volume and serum prostate-specific antigen levels
  Urology, 1994
• Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
  Published by American Medical Association (AMA) ,1994
• Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer
  Cancer, 1993
• Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
  JAMA, 1992
• Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
  New England Journal of Medicine, 1987